CC vs. ALTM, ESI, CSWI, AVNT, PCT, MEOH, PRM, UAN, NGVT, and BAK
Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include Arcadium Lithium (ALTM), Element Solutions (ESI), CSW Industrials (CSWI), Avient (AVNT), PureCycle Technologies (PCT), Methanex (MEOH), Perimeter Solutions (PRM), CVR Partners (UAN), Ingevity (NGVT), and Braskem (BAK). These companies are all part of the "chemicals" industry.
Chemours vs. Its Competitors
Chemours (NYSE:CC) and Arcadium Lithium (NYSE:ALTM) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.
In the previous week, Chemours had 6 more articles in the media than Arcadium Lithium. MarketBeat recorded 6 mentions for Chemours and 0 mentions for Arcadium Lithium. Chemours' average media sentiment score of 0.37 beat Arcadium Lithium's score of 0.00 indicating that Chemours is being referred to more favorably in the media.
76.3% of Chemours shares are held by institutional investors. Comparatively, 27.0% of Arcadium Lithium shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 0.4% of Arcadium Lithium shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Chemours has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Arcadium Lithium has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500.
Arcadium Lithium has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Arcadium Lithium, indicating that it is currently the more affordable of the two stocks.
Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.8%. Arcadium Lithium pays an annual dividend of $6.00 per share and has a dividend yield of 102.7%. Chemours pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Arcadium Lithium pays out 7,500.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Chemours currently has a consensus price target of $17.33, indicating a potential upside of 36.21%. Given Chemours' stronger consensus rating and higher probable upside, equities analysts plainly believe Chemours is more favorable than Arcadium Lithium.
Chemours has a net margin of 0.54% compared to Arcadium Lithium's net margin of 0.00%. Chemours' return on equity of 23.82% beat Arcadium Lithium's return on equity.
Summary
Chemours beats Arcadium Lithium on 14 of the 18 factors compared between the two stocks.
Get Chemours News Delivered to You Automatically
Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Chemours Competitors List
Related Companies and Tools
This page (NYSE:CC) was last updated on 7/5/2025 by MarketBeat.com Staff
Free CC Stock Alerts